The status of drug resistance and ampC gene expression in Enterobacter cloacae

Chinese Medical Journal

Volumn 116, Issue 8, 2003, Pages 1244-1247

  Zhou, Zhihui ^a   Li, Lanjuan ^a   Yu, Yunsong ^a   Ma, Yilin ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Beta lactamase ampC; Drug resistance ampC gene; Enterobacter cloacae

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; CLAVULANIC ACID; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DNA SEQUENCE; ENTEROBACTER CLOACAE; GENE EXPRESSION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

BETA-LACTAMASES; CEFOPERAZONE; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER CLOACAE; GENE EXPRESSION; GENES, BACTERIAL; IMIPENEM; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; SULBACTAM;

EID: 0041829085     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Jones RN. Important and emerging β-lactamase-mediated resistance in hospital-based pathogens: ampC enzymes. Diagn Microbiol Infect Dis 1998;31:441-446.
2. Barnaud G, Labia R, Raskine L, et al. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloaca clinical isolate. FEMS Microbiol Lett 2001;195:185-190.
3. Bush K, Jacoby GA, Mederios AA. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995;39: 1211-1233.
4. Stapleton P, Shannon K, Phillips I. DNA sequence differences of ampD mutants of Citrobacter freundii. Antimicrob Agents Chemother 1995;39:2494-2498.
5. Normark S. β-lactamase induction in Gram-negative bacteria is intimately linked to peptidoglycan recycling. Microb Drug Resist 1995;1:111-114.
6. Livermore DM. β-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995;8:557-584.
7. Horii T, Arakawa Y, Ohta M, et al. Characterization of a plasmid borne and constitutively expressed blaMOX-1 gene encoding AmpC-type β-lactamase. Gene 1994;139:93-98.
8. Bauernfeind A, Wagner S, Jungwirth R, et al. A novel Class C β-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins. Antimicrob Agents Chemother 1997;41:2041-2046.
9. Campbell JIA, Cilfu O, Hoiby N. Pseudomonas aeruginosa isolates from patients with cystic fibrosis have different β-lactamase expression phenotypes but are homogeneous in the ampC-ampR genetic region. Antimicrob Agents Chemother 1997;41:1380-1384.
10. Wai CC, Ronald CL, Julia ML, et al. Markedly different rates and resistance profiles exhibited by sever commonly used and newer β-lactams on the selection of resistant variants of Enterobacter cloacae. J Antimicrob Chem 1999;43:55-60.